Restart Life Sciences Financial Overview
Restart Life Sciences's market cap is currently $3.34M. The company's EPS TTM is $-0.004284948; its P/E ratio is -2.73; Restart Life Sciences is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
